期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 21, 期 23, 页码 7155-7165出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2011.09.078
关键词
p38 Kinase; Virtual fragment-based drug design; DFG-out conformation
Discovery of a new class of DFG-out p38 alpha kinase inhibitors with no hinge interaction is described. A computationally assisted, virtual fragment-based drug design (vFBDD) platform was utilized to identify novel non-aromatic fragments which make productive hydrogen bond interactions with Arg 70 on the alpha C-helix. Molecules incorporating these fragments were found to be potent inhibitors of p38 kinase. X-ray co-crystal structures confirmed the predicted binding modes. A lead compound was identified as a potent (p38 alpha IC(50) = 22 nM) and highly selective (>= 150-fold against 150 kinase panel) DFG-out p38 kinase inhibitor. (C) 2011 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据